IN-DATE
383512-SD: BD Nexiva Closed IV Catheter, Single-Port 22G x 1"
Sign in to add this product to your favorites!
| Price: | $99.99 per box of 20 |
|---|---|
| Quantity: | |
| In Stock: | 7 box of 20 |
| Expiration: | 07-2025 |
| Express: | Need it tomorrow? Order in next 6 hours 39 minutes and choose overnight shipping at checkout for Monday delivery. If you require Saturday delivery, please call to determine if it is available in your area - 888-416-2409. |
Related Items
QUICK VIEW
| 383552-SD - Size: 22G $79.99 per box of 20 BD Nexiva Closed IV Catheter 22G x 1" Single Port w/MaxZero Exp: 11-2025 Units in stock: 48 box of 20 | Order Qty |
QUICK VIEW
| 383532-SD - Size: 22G $109.99 per box of 20 BD Nexiva Closed IV Catheter 22G x 1" Y w/Dual Q-Syte Exp: 09-2025 Units in stock: 2 box of 20 | Order Qty |
|
QUICK VIEW
| 383553-SD - Size: 22G $99.99 per box of 20 BD Nexiva Closed IV Catheter 22G x 1.75" Single Port w/MaxZero Exp: 07-2025 Units in stock: 1 box of 20 | Order Qty |
Additional Details
BD Nexiva
Single-Port
- Catheter's stabilization platform minimizes movement that can lead to catheter complications, restarts and associated costs
- Proprietary BD Vialon™ Biomaterial enables longer dwell times, supporting the current Infusion Nursing Standards of Practice for clinically indicated site rotation
- Designed to minimize treatment delays and complications
- BD Instaflash™ Needle Technology quick blood visualization may help improve insertion success, and therefore reduce insertion attempts
Manufacturer
Becton, Dickinson and Company (BD) is a global medical technology leader providing a broad range of products across medication management, diagnostics, and surgical care. BD’s Medical segment includes industry-leading solutions in medication delivery, such as BD syringes, needles, and infusion systems, as well as devices for diabetes care and pharmaceutical pre-fillable systems. The Life Sciences division supports clinical diagnostics and research with products like BD Vacutainer blood collection systems and BD Veritor rapid testing platforms. BD’s Interventional segment includes advanced surgical products from acquired brands like Bard and Tepha, with specialties in infection prevention, hernia repair, biosurgery, and urology. With a focus on advancing health through technology, BD supports hospitals, labs, and clinicians worldwide in improving safety, efficiency, and patient outcomes.
